AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company’s lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.
Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for AcelRx Pharmaceuticals, Inc. (ACRX)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
2 days ago | Newsfile Corp
5 days ago | PRNewsWire
6 days ago | Newsfile Corp
6 days ago | Newsfile Corp
6 days ago | Newsfile Corp
6 days ago | PRNewsWire
a week ago | Newsfile Corp
a week ago | Newsfile Corp
a week ago | Business Wire